FALCONE, ALFREDO Statistiche
FALCONE, ALFREDO
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
In corso di stampa DEL RE, Marzia; Tiseo, Marcello; Bordi, Paola; D'Incecco, Armida; Camerini, Andrea; Petrini, Iacopo; Lucchesi, Maurizio; Inno, Alessandro; Spada, Daniele; Vasile, Enrico; Citi, Valentina; Malpeli, Giorgio; Testa, Enrica; Gori, Stefania; Falcone, Alfredo; Amoroso, Domenico; Chella, Antonio; Cappuzzo, Federico; Ardizzoni, Andrea; Scarpa, Aldo; Danesi, Romano
Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives
In corso di stampa Folprecht, G.; Martinelli, E.; Mazard, T.; Modest, D. P.; Tsuji, A.; Esser, R.; Cremolini, C.; Falcone, A.
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials
2023-01-01 Wang, Jingyuan; Millstein, Joshua; Yang, Yan; Stintzing, Sebastian; Arai, Hiroyuki; Battaglin, Francesca; Kawanishi, Natsuko; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Cremolini, Chiara; Liu, Tianshu; Heinemann, Volker; Falcone, Alfredo; Shen, Lin; Lenz, Heinz-Josef
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
2022-01-01 Conte, P; Ascierto, P A; Patelli, G; Danesi, R; Vanzulli, A; Sandomenico, F; Tarsia, P; Cattelan, A; Comes, A; De Laurentiis, M; Falcone, A; Regge, D; Richeldi, L; Siena, S
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials
2022-01-01 Wang, Jingyuan; Xiao, Yi; Loupakis, Fotios; Stintzing, Sebastian; Yang, Yan; Arai, Hiroyuki; Battaglin, Francesca; Kawanishi, Natsuko; Jayachandran, Priya; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Cremolini, Chiara; Liu, Tianshu; Heinemann, Volker; Falcone, Alfredo; Shen, Lin; Millstein, Joshua; Lenz, Heinz-Josef
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies
2021-01-01 Moretto, R.; Rossini, D.; Conca, V.; Lonardi, S.; Rasola, C.; Antoniotti, C.; Santini, D.; Marmorino, F.; Tomasello, G.; Borelli, B.; Caponnetto, S.; Zucchelli, G.; Zaniboni, A.; Ambrosini, M.; Buonadonna, A.; Fanchini, L.; Cupini, S.; Masi, G.; Falcone, A.; Cremolini, C.
Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial
2021-01-01 Martinelli, E.; Martini, G.; Famiglietti, V.; Troiani, T.; Napolitano, S.; Pietrantonio, F.; Ciardiello, D.; Terminiello, M.; Borrelli, C.; Vitiello, P. P.; De Braud, F.; Morano, F.; Avallone, A.; Normanno, N.; Nappi, A.; Maiello, E.; Latiano, T.; Falcone, A.; Cremolini, C.; Rossini, D.; Santabarbara, G.; Pinto, C.; Santini, D.; Cardone, C.; Zanaletti, N.; Di Liello, A.; Renato, D.; Esposito, L.; Marrone, F.; Ciardiello, F.
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
2021-01-01 Rossini, D; Boccaccino, A; Sbrana, A; Daniel, F; Borelli, B; Raimondi, A; Santini, D; Conca, V; Tomasello, G; Caponnetto, S; Marmorino, F; Zaniboni, A; Buonadonna, A; Masi, G; Lonardi, S; Pietrantonio, F; Falcone, A; Antonuzzo, A; Cremolini, C
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer
2021-01-01 Suenaga, M.; Schirripa, M.; Cao, S.; Zhang, W.; Cremolini, C.; Lonardi, S.; Okazaki, S.; Berger, M. D.; Miyamoto, Y.; Soni, S.; Barzi, A.; Yamaguchi, T.; Loupakis, F.; Falcone, A.; Lenz, H. -J.
Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma
2021-01-01 Bianchini, M.; Giambelluca, M. A.; Scavuzzo, M. C.; Di Franco, G.; Guadagni, S.; Palmeri, M.; Furbetta, N.; Gianardi, D.; Funel, N.; Ricci, C.; Gaeta, R.; Pollina, L. E.; Falcone, A.; Vivaldi, C.; Di Candio, G.; Biagioni, F.; Busceti, C. L.; Morelli, L.; Fornai, F.
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study
2021-01-01 Moretto, R.; Giordano, M.; Poma, A. M.; Passardi, A.; Boccaccino, A.; Tomasello, G.; Aprile, G.; Conca, V.; Granetto, C.; Frassoldati, A.; Clavarezza, M.; Bertolini, A. S.; Germani, M. M.; Ugolini, C.; Fontanini, G.; Masi, G.; Falcone, A.; Cremolini, C.
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer
2021-01-01 Arai, H.; Millstein, J.; Loupakis, F.; Stintzing, S.; Wang, J.; Battaglin, F.; Kawanishi, N.; Jayachandran, P.; Soni, S.; Zhang, W.; Mumenthaler, S. M.; Cremolini, C.; Heinemann, V.; Falcone, A.; Lenz, H. -J.
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications
2021-01-01 Moretto, Roberto; Elliott, Andrew; Zhang, Jian; Arai, Hiroyuki; Germani, Marco Maria; Conca, Veronica; Xiu, Joanne; Stafford, Phillip; Oberley, Matthew; Abraham, Jim; Spetzler, David; Rossini, Daniele; Antoniotti, Carlotta; Marshall, John; Shields, Anthony; Lopes, Gilberto; Lonardi, Sara; Pietrantonio, Filippo; Tomasello, Gianluca; Passardi, Alessandro; Tamburini, Emiliano; Santini, Daniele; Aprile, Giuseppe; Masi, Gianluca; Falcone, Alfredo; Lenz, Heinz-Josef; Korn, Michael; Cremolini, Chiara
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade
2021-01-01 Brancatella, Alessandro; Lupi, Isabella; Montanelli, Lucia; Ricci, Debora; Viola, Nicola; Sgrò, Daniele; Antonangeli, Lucia; Sardella, Chiara; Brogioni, Sandra; Piaggi, Paolo; Molinaro, Eleonora; Bianchi, Francesca; Aragona, Michele; Antonuzzo, Andrea; Sbrana, Andrea; Lucchesi, Maurizio; Chella, Antonio; Falcone, Alfredo; Del Prato, Stefano; Elisei, Rossella; Marcocci, Claudio; Caturegli, Patrizio; Santini, Ferruccio; Latrofa, Francesco
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study
2021-01-01 Borelli, B.; Fontana, E.; Giordano, Mirella.; Antoniotti, Carlotta.; Lonardi, S.; Bergamo, F.; Pietrantonio, F.; Morano, F.; Tamburini, E.; Boccaccino, Alessandra.; Santini, D.; Zucchelli, G.; Pella, N.; Maiello, E.; Passardi, A.; Zaniboni, A.; Ugolini, C.; Fontanini, Gabriella.; Falcone, Alfredo.; Nyamundanda, G.; Sadanandam, A.; Cremolini, C.
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients
2021-01-01 Naseem, M.; Cao, S.; Yang, D.; Millstein, J.; Puccini, A.; Loupakis, F.; Stintzing, S.; Cremolini, C.; Tokunaga, R.; Battaglin, F.; Soni, S.; Berger, M. D.; Barzi, A.; Zhang, W.; Falcone, A.; Heinemann, V.; Lenz, H. -J.
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients
2021-01-01 Moretto, R.; Rossini, D.; Capone, I.; Boccaccino, A.; Perrone, F.; Tamborini, E.; Masi, G.; Antoniotti, C.; Marmorino, F.; Conca, V.; Borelli, B.; Martignetti, A.; Pecora, I.; Simionato, F.; Cupini, S.; Ambrosini, M.; Manca, P.; Pietrantonio, F.; Falcone, A.; Cremolini, C.
RNA-binding protein polymorphisms as novel biomarkers to predict outcomes of metastatic colorectal cancer: A meta-analysis from TRIBE, FIRE-3, and MAVERICC
2021-01-01 Arai, H.; Cao, S.; Battaglin, F.; Wang, J.; Kawanishi, N.; Tokunaga, R.; Loupakis, F.; Stintzing, S.; Soni, S.; Zhang, W.; Mancao, C.; Salhia, B.; Mumenthaler, S. M.; Cremolini, C.; Heinemann, V.; Falcone, A.; Millstein, J.; Lenz, H. -J.
Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients
2021-01-01 Catanese, Silvia; Aringhieri, Giacomo; Vivaldi, Caterina; Salani, Francesca; Vitali, Saverio; Pecora, Irene; Massa, Valentina; Lencioni, Monica; Vasile, Enrico; Tintori, Rachele; Balducci, Francesco; Falcone, Alfredo; Cappelli, Carla; Fornaro, Lorenzo
Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study
2021-01-01 Antoniotti, C.; Korn, W. M.; Marmorino, F.; Rossini, D.; Lonardi, S.; Masi, G.; Randon, G.; Conca, V.; Boccaccino, A.; Tomasello, G.; Passardi, A.; Swensen, J.; Ugolini, C.; Oberley, M.; Tamburini, E.; Casagrande, M.; Domenyuk, V.; Fontanini, G.; Giordano, M.; Abraham, J.; Spetzler, D.; Falcone, A.; Lenz, H. -J.; Cremolini, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA | In corso di stampa | DEL RE, Marzia; Tiseo, Marcello; Bordi, Paola; D'Incecco, Armida; Camerini, Andrea; Petrini, Iacopo; Lucchesi, Maurizio; Inno, Alessandro; Spada, Daniele; Vasile, Enrico; Citi, Valentina; Malpeli, Giorgio; Testa, Enrica; Gori, Stefania; Falcone, Alfredo; Amoroso, Domenico; Chella, Antonio; Cappuzzo, Federico; Ardizzoni, Andrea; Scarpa, Aldo; Danesi, Romano | |
| Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives | In corso di stampa | Folprecht, G.; Martinelli, E.; Mazard, T.; Modest, D. P.; Tsuji, A.; Esser, R.; Cremolini, C.; Falcone, A. | |
| Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials | 1-gen-2023 | Wang, Jingyuan; Millstein, Joshua; Yang, Yan; Stintzing, Sebastian; Arai, Hiroyuki; Battaglin, Francesca; Kawanishi, Natsuko; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Cremolini, Chiara; Liu, Tianshu; Heinemann, Volker; Falcone, Alfredo; Shen, Lin; Lenz, Heinz-Josef | |
| Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment | 1-gen-2022 | Conte, P; Ascierto, P A; Patelli, G; Danesi, R; Vanzulli, A; Sandomenico, F; Tarsia, P; Cattelan, A; Comes, A; De Laurentiis, M; Falcone, A; Regge, D; Richeldi, L; Siena, S | |
| Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials | 1-gen-2022 | Wang, Jingyuan; Xiao, Yi; Loupakis, Fotios; Stintzing, Sebastian; Yang, Yan; Arai, Hiroyuki; Battaglin, Francesca; Kawanishi, Natsuko; Jayachandran, Priya; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Cremolini, Chiara; Liu, Tianshu; Heinemann, Volker; Falcone, Alfredo; Shen, Lin; Millstein, Joshua; Lenz, Heinz-Josef | |
| CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | 1-gen-2021 | Moretto, R.; Rossini, D.; Conca, V.; Lonardi, S.; Rasola, C.; Antoniotti, C.; Santini, D.; Marmorino, F.; Tomasello, G.; Borelli, B.; Caponnetto, S.; Zucchelli, G.; Zaniboni, A.; Ambrosini, M.; Buonadonna, A.; Fanchini, L.; Cupini, S.; Masi, G.; Falcone, A.; Cremolini, C. | |
| Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial | 1-gen-2021 | Martinelli, E.; Martini, G.; Famiglietti, V.; Troiani, T.; Napolitano, S.; Pietrantonio, F.; Ciardiello, D.; Terminiello, M.; Borrelli, C.; Vitiello, P. P.; De Braud, F.; Morano, F.; Avallone, A.; Normanno, N.; Nappi, A.; Maiello, E.; Latiano, T.; Falcone, A.; Cremolini, C.; Rossini, D.; Santabarbara, G.; Pinto, C.; Santini, D.; Cardone, C.; Zanaletti, N.; Di Liello, A.; Renato, D.; Esposito, L.; Marrone, F.; Ciardiello, F. | |
| Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO | 1-gen-2021 | Rossini, D; Boccaccino, A; Sbrana, A; Daniel, F; Borelli, B; Raimondi, A; Santini, D; Conca, V; Tomasello, G; Caponnetto, S; Marmorino, F; Zaniboni, A; Buonadonna, A; Masi, G; Lonardi, S; Pietrantonio, F; Falcone, A; Antonuzzo, A; Cremolini, C | |
| Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer | 1-gen-2021 | Suenaga, M.; Schirripa, M.; Cao, S.; Zhang, W.; Cremolini, C.; Lonardi, S.; Okazaki, S.; Berger, M. D.; Miyamoto, Y.; Soni, S.; Barzi, A.; Yamaguchi, T.; Loupakis, F.; Falcone, A.; Lenz, H. -J. | |
| Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma | 1-gen-2021 | Bianchini, M.; Giambelluca, M. A.; Scavuzzo, M. C.; Di Franco, G.; Guadagni, S.; Palmeri, M.; Furbetta, N.; Gianardi, D.; Funel, N.; Ricci, C.; Gaeta, R.; Pollina, L. E.; Falcone, A.; Vivaldi, C.; Di Candio, G.; Biagioni, F.; Busceti, C. L.; Morelli, L.; Fornai, F. | |
| Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study | 1-gen-2021 | Moretto, R.; Giordano, M.; Poma, A. M.; Passardi, A.; Boccaccino, A.; Tomasello, G.; Aprile, G.; Conca, V.; Granetto, C.; Frassoldati, A.; Clavarezza, M.; Bertolini, A. S.; Germani, M. M.; Ugolini, C.; Fontanini, G.; Masi, G.; Falcone, A.; Cremolini, C. | |
| Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer | 1-gen-2021 | Arai, H.; Millstein, J.; Loupakis, F.; Stintzing, S.; Wang, J.; Battaglin, F.; Kawanishi, N.; Jayachandran, P.; Soni, S.; Zhang, W.; Mumenthaler, S. M.; Cremolini, C.; Heinemann, V.; Falcone, A.; Lenz, H. -J. | |
| Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications | 1-gen-2021 | Moretto, Roberto; Elliott, Andrew; Zhang, Jian; Arai, Hiroyuki; Germani, Marco Maria; Conca, Veronica; Xiu, Joanne; Stafford, Phillip; Oberley, Matthew; Abraham, Jim; Spetzler, David; Rossini, Daniele; Antoniotti, Carlotta; Marshall, John; Shields, Anthony; Lopes, Gilberto; Lonardi, Sara; Pietrantonio, Filippo; Tomasello, Gianluca; Passardi, Alessandro; Tamburini, Emiliano; Santini, Daniele; Aprile, Giuseppe; Masi, Gianluca; Falcone, Alfredo; Lenz, Heinz-Josef; Korn, Michael; Cremolini, Chiara | |
| Management of thyrotoxicosis induced by PD1 or PD-L1 blockade | 1-gen-2021 | Brancatella, Alessandro; Lupi, Isabella; Montanelli, Lucia; Ricci, Debora; Viola, Nicola; Sgrò, Daniele; Antonangeli, Lucia; Sardella, Chiara; Brogioni, Sandra; Piaggi, Paolo; Molinaro, Eleonora; Bianchi, Francesca; Aragona, Michele; Antonuzzo, Andrea; Sbrana, Andrea; Lucchesi, Maurizio; Chella, Antonio; Falcone, Alfredo; Del Prato, Stefano; Elisei, Rossella; Marcocci, Claudio; Caturegli, Patrizio; Santini, Ferruccio; Latrofa, Francesco | |
| Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study | 1-gen-2021 | Borelli, B.; Fontana, E.; Giordano, Mirella.; Antoniotti, Carlotta.; Lonardi, S.; Bergamo, F.; Pietrantonio, F.; Morano, F.; Tamburini, E.; Boccaccino, Alessandra.; Santini, D.; Zucchelli, G.; Pella, N.; Maiello, E.; Passardi, A.; Zaniboni, A.; Ugolini, C.; Fontanini, Gabriella.; Falcone, Alfredo.; Nyamundanda, G.; Sadanandam, A.; Cremolini, C. | |
| Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients | 1-gen-2021 | Naseem, M.; Cao, S.; Yang, D.; Millstein, J.; Puccini, A.; Loupakis, F.; Stintzing, S.; Cremolini, C.; Tokunaga, R.; Battaglin, F.; Soni, S.; Berger, M. D.; Barzi, A.; Zhang, W.; Falcone, A.; Heinemann, V.; Lenz, H. -J. | |
| Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients | 1-gen-2021 | Moretto, R.; Rossini, D.; Capone, I.; Boccaccino, A.; Perrone, F.; Tamborini, E.; Masi, G.; Antoniotti, C.; Marmorino, F.; Conca, V.; Borelli, B.; Martignetti, A.; Pecora, I.; Simionato, F.; Cupini, S.; Ambrosini, M.; Manca, P.; Pietrantonio, F.; Falcone, A.; Cremolini, C. | |
| RNA-binding protein polymorphisms as novel biomarkers to predict outcomes of metastatic colorectal cancer: A meta-analysis from TRIBE, FIRE-3, and MAVERICC | 1-gen-2021 | Arai, H.; Cao, S.; Battaglin, F.; Wang, J.; Kawanishi, N.; Tokunaga, R.; Loupakis, F.; Stintzing, S.; Soni, S.; Zhang, W.; Mancao, C.; Salhia, B.; Mumenthaler, S. M.; Cremolini, C.; Heinemann, V.; Falcone, A.; Millstein, J.; Lenz, H. -J. | |
| Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients | 1-gen-2021 | Catanese, Silvia; Aringhieri, Giacomo; Vivaldi, Caterina; Salani, Francesca; Vitali, Saverio; Pecora, Irene; Massa, Valentina; Lencioni, Monica; Vasile, Enrico; Tintori, Rachele; Balducci, Francesco; Falcone, Alfredo; Cappelli, Carla; Fornaro, Lorenzo | |
| Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study | 1-gen-2021 | Antoniotti, C.; Korn, W. M.; Marmorino, F.; Rossini, D.; Lonardi, S.; Masi, G.; Randon, G.; Conca, V.; Boccaccino, A.; Tomasello, G.; Passardi, A.; Swensen, J.; Ugolini, C.; Oberley, M.; Tamburini, E.; Casagrande, M.; Domenyuk, V.; Fontanini, G.; Giordano, M.; Abraham, J.; Spetzler, D.; Falcone, A.; Lenz, H. -J.; Cremolini, C. |